Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting

Interactive Cardiovascular and Thoracic Surgery

Volumn 10, Issue 4, 2010, Pages 555-560

  Nakahira, Atsushi ^a   Sasaki, Yasuyuki ^a   Hirai, Hidekazu ^a   Fukui, Toshihiro ^a   Matsuo, Mitsunori ^b   Takahashi, Yosuke ^a   Kotani, Shinsuke ^a   Suehiro, Shigefumi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cardiopulmonary bypass; Coronary artery bypass grafting; Thrombin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; D DIMER; FIBRINOGEN DEGRADATION PRODUCT; FRESH FROZEN PLASMA; HEPARIN; PLASMINOGEN; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE TRANSFUSION; FEMALE; FIBRINOLYSIS; HEMATOCRIT; HUMAN; INTERMETHOD COMPARISON; MALE; MATERIAL COATING; OPERATION DURATION; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTHROMBIN TIME; SUCTION DRAINAGE; SURGICAL EQUIPMENT; SURGICAL PATIENT; SURGICAL TECHNIQUE; THROMBOCYTE COUNT;

AGED; ANTICOAGULANTS; ANTITHROMBIN III; BLOOD COAGULATION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY BYPASS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HEMATOCRIT; HEPARIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PEPTIDE HYDROLASES; PLATELET COUNT; PROSPECTIVE STUDIES; SUCTION; THROMBIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950664341     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.214437     Document Type: Article

References (13)

1. Mazzei V, Nasso G, Salamone G, Castorino F, Tommasini A, Anselmi A. Prospective randomized comparison of coronary bypass grafting with minimal extracorporeal circulation system (MECC) versus off-pump coronary surgery. Circulation 2007;116:1761-1767.
2. Kamiya H, Kofidis T, Haverich A, Klima U. Preliminary experience with the mini-extracorporeal circulation system (Medtronic resting heart system). Interact CardioVasc Thorac Surg 2006;5:680-682.
3. Ti LK, Goh BL, Wong PS, Ong P, Goh SG, Lee CN. Comparison of minicardiopulmonary bypass system with air-purge device to conventional bypass system. Ann Thorac Surg 2008;85:994-1000.
4. Perthel M, El-Ayoubi L, Bendisch A, Laas J, Gerigk M. Clinical advantages of using mini-bypass systems in terms of blood product use, postoperative bleeding and air entrainment: an in vivo clinical perspective. Eur J Cardiothorac Surg 2007;31:1070-1075.
5. Fromes Y, Gaillard D, Ponzio O, Chauffert M, Gerhardt MF, Deleuze P, Bical OM. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 2002;22:527-533.
6. Just SS, Müller T, Hartrumpf M, Albes JM. First experience with closed circuitycentrifugal pump extracorporeal circulation: cellular trauma, coagulatory, and inflammatory response. Interact CardioVasc Thorac Surg 2006;5:646-648.
7. Vedin J, Antovic A, Ericsson A, Vaage J. Hemostasis in off-pump compared to on-pump coronary artery bypass grafting: a prospective, randomized study. Ann Thorac Surg 2005;80:586-593.
8. De Somer F, Van Belleghem Y, Caes F, François K, Van Overbeke H, Arnout J, Taeymans Y, Van Nooten G. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2002;123:951-958.
9. Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds LH Jr. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 1996;93:2014-2018.
10. Philippou H, Adami A, Davidson SJ, Pepper JR, Burman JF, Lane DA. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. Thromb Haemost 2000;84:124-128.
11. Tanaka H, Oshiyama T, Narisawa T, Mori T, Masuda M, Kishi D, Kitou T, Miyazima S. Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits. J Artif Organs 2003; 6:245-252.
12. Aldea GS, Soltow LO, Chandler WL, Triggs CM, Vocelka CR, Crockett GI, Shin YT, Curtis WE, Verrier ED. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002;123:742-755.
13. Fabre O, Vincentelli A, Corseaux D, Juthier F, Susen S, Bauters A, Van Belle E, Mouquet F, Le Tourneau T, Decoene C, Crépin F, Prat A, Jude B. Comparison of blood activation in the wound, active vent, and cardiopulmonary bypass circuit. Ann Thorac Surg 2008;86:537-541.